All articles by GlobalData Healthcare

TB or not TB: WHO releases new TB diagnostic guidelines ahead of World TB Day

World Tuberculosis Day will be celebrated on 24 March, and new recommendations for tuberculosis (TB) diagnostic techniques from the World…
Population patterns of CKD: the role of age and sex

World Kidney Day, observed each year in March, draws attention to the global burden of kidney disease and the importance…
Silent spread, serious consequences: the shifting trends of AMR

Antimicrobial resistance (AMR) occurs when bacteria change in ways that make antibiotics less effective. As a result, infections that were…
Kidney disease risk higher after Covid infection than after influenza infection

Covid-19 has been associated with an increased risk of a variety of disorders, including cardiovascular disease, clotting disorders, diabetes, chronic…
Largest study of vegetarian diets to date shows reduced risk of five cancers

Cancer is a leading cause of death worldwide, accounting for nearly 1 in 6 deaths in 2020, according to the…

Illicit drug use associated with increased odds of stroke

According to the World Health Organization, stroke was the third leading cause of death and disability globally in 2021, and…
Preclinical data for MDL-001 indicates potential across multiple viral infections

Model Medicines presented an update on its lead candidate, MDL-001, at the Biocom Global Partnering Conference in California. MDL-001 is…
Study explores links between gestational diabetes, prenatal depression and childhood obesity

In the US, the burden of childhood obesity has posed a formidable public health problem. Obesity in early life predisposes…
Long-term aspirin use is associated with lower ovarian cancer risk

Ovarian cancer is a leading cause of gynaecological cancer mortality worldwide. Early symptoms of ovarian cancer can include decreased appetite,…
ArgenX highlights new Vyvgart data, demonstrating early disease control in ocular MG

On 26 February, ArgenX announced results from additional analyses of its blockbuster FcRn inhibitor Vyvgart in the Phase III Adapt…